Article Information
History
- September 12, 2021.
Article Versions
- You are currently viewing Version 1 of this article (September 12, 2021 - 15:39).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Matthew T Laurie1,
- Jamin Liu1,2,
- Sara Sunshine1,
- James Peng3,
- Douglas Black3,
- Anthea M Mitchell1,4,
- Sabrina A Mann1,4,
- Genay Pilarowski5,6,
- Kelsey C Zorn1,
- Luis Rubio3,
- Sara Bravo6,
- Carina Marquez3,
- Maya Petersen7,
- Diane Havlir3 and
- Joseph DeRisi1,4,*
- 1Department of Biochemistry and Biophysics, University of California San Francisco, CA 94143, USA
- 2University of California, Berkeley-University of California, San Francisco Graduate Program in Bioengineering, Berkeley, CA 94720, USA
- 3Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA
- 4Chan Zuckerberg Biohub, San Francisco, CA 94158, USA
- 5The Public Health Company, Oakland, CA 94610, USA
- 6Unidos en Salud, San Francisco, CA, 94143, USA
- 7Division of Biostatistics, University of California, Berkeley, Berkeley, CA 94720, USA
- ↵*Corresponding author: Joseph DeRisi, 1700 4th St., San Francisco, CA 94158, Phone:415-418-3647, Email: joe{at}derisilab.ucsf.edu
Posted September 12, 2021.
Exposures to different SARS-CoV-2 spike variants elicit neutralizing antibody responses with differential specificity towards established and emerging strains
